GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Diabetes Mellitus, Type 2Non-Insulin-Dependent Diabetes Mellitus

Interventions

DRUG

GSK189075 oral tablets

DRUG

GW869682 oral tablets

Trial Locations (3)

GSK Investigational Site, Berlin

GSK Investigational Site, Neuss

GSK Investigational Site, Chula Vista